Evofem Biosciences, Inc.
EVFM · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $0 | $1 | $0 | $1 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $4 | $5 | $1 | $10 |
| Inventory | $2 | $2 | $2 | $2 |
| Other Curr. Assets | $2 | $1 | $2 | $1 |
| Total Curr. Assets | $8 | $9 | $6 | $14 |
| Property Plant & Equip (Net) | $1 | $1 | $0 | $1 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $5 | $5 | $6 | $10 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $6 | $5 | $7 | $10 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $14 | $14 | $13 | $24 |
| Liabilities | – | – | – | – |
| Payables | $12 | $12 | $11 | $16 |
| Short-Term Debt | $65 | $47 | $46 | $46 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $2 | $11 | $11 | $13 |
| Total Curr. Liab. | $78 | $74 | $71 | $80 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $6 | $5 | $7 | $10 |
| Total NC Liab. | $6 | $10 | $12 | $15 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $84 | $84 | $82 | $95 |
| Equity | – | – | – | – |
| Pref Stock | $5 | $5 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$900 | -$898 | -$897 | -$898 |
| AOCI | -$7 | -$3 | -$2 | -$3 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | -$70 | -$70 | -$70 | -$71 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $14 | $14 | $13 | $24 |
| Net Debt | $65 | $46 | $45 | $45 |